Hemogenyx Pharmaceuticals PLC (HEMO) — Net Asset Quality Index
Hemogenyx Pharmaceuticals PLC (HEMO) has a Net Asset Quality Index of -17.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX3.10 Million minus total liabilities of GBX3.65 Million yields net assets of GBX-546.41K. A higher index indicates a stronger, lower-leverage balance sheet. See HEMO days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hemogenyx Pharmaceuticals PLC Net Asset Quality Index Over Time (2015–2024)
This chart shows how Hemogenyx Pharmaceuticals PLC's Net Asset Quality Index has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the index stands at -17.6%, representing net assets of GBX-546.41K against total assets of GBX3.10 Million GBX. Explore cash efficiency ratio of Hemogenyx Pharmaceuticals PLC to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Hemogenyx Pharmaceuticals PLC (2015–2024)
The table below presents the year-by-year Net Asset Quality Index for Hemogenyx Pharmaceuticals PLC from 2015 to 2024, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see HEMO stock market capitalisation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 20.3% | GBX853.49K | GBX4.21 Million | GBX3.36 Million | ▼ -25.3 pp |
| 2023 | 45.5% | GBX2.78 Million | GBX6.11 Million | GBX3.32 Million | ▼ -0.2 pp |
| 2022 | 45.7% | GBX3.24 Million | GBX7.09 Million | GBX3.85 Million | ▼ -50.1 pp |
| 2021 | 95.9% | GBX8.17 Million | GBX8.52 Million | GBX352.84K | ▲ +63.0 pp |
| 2020 | 32.9% | GBX875.68K | GBX2.66 Million | GBX1.79 Million | ▲ +66.1 pp |
| 2019 | -33.2% | GBX-349.04K | GBX1.05 Million | GBX1.40 Million | ▼ -75.0 pp |
| 2018 | 41.7% | GBX959.17K | GBX2.30 Million | GBX1.34 Million | ▼ -47.3 pp |
| 2017 | 89.0% | GBX2.13 Million | GBX2.40 Million | GBX263.69K | ▲ +2.7 pp |
| 2016 | 86.3% | GBX903.71K | GBX1.05 Million | GBX143.69K | ▲ +62.3 pp |
| 2015 | 24.0% | GBX77.82K | GBX324.65K | GBX246.83K | — |